Moderna | العاصمة قرض



Loan Capital تغيير تاريخ
Acadia Pharmaceuticals USD 0 0 2024-12
Adcock Ingram Holdings ZAR 238.08M 21.45M 2024-06
Agios Pharmaceuticals USD 0 0 2024-12
Alnylam Pharmaceuticals USD 1.02B 967K 2024-12
Amgen USD 56.55B 305M 2024-12
Arrowhead Research USD 407.79M 14.61M 2024-12
Biogen USD 4.55B 1.4M 2024-12
BioMarin Pharmaceutical USD 595.89M 1.27M 2024-12
Celltrion KRW 79.58B 21.94B 2024-09
Cspc Pharmaceutical CNY 66.32M 40.74M 2024-06
Dianthus Therapeutics USD 0 0 2024-09
Gilead Sciences USD 24.9B 3.46B 2024-12
GlaxoSmithKline GBP 14.64B 1.39B 2024-12
Incyte USD 33.54M 5.32M 2024-12
Ionis Pharmaceuticals USD 1.25B 11.67M 2024-12
Kangmei Pharma CNY 169.19M 7.26M 2024-09
Knight Therapeutics CAD 36.51M 2.04M 2024-09
Laboratorios Farma EUR 98.14M 45.9M 2024-06
Malin Corporation EUR 0 0 2024-06
Moderna USD 39M 586M 2024-12
Organigram Holdings CAD 43.29M 12.19M 2024-12
Pharma Mar EUR 41.23M 999K 2024-12
Qiagen NV USD 1.34B 26.51M 2024-12
Regeneron Pharmaceuticals USD 2.7B 720.4M 2024-12
Sarepta Therapeutics USD 1.14B 1.16M 2024-12
Sartorius EUR 4.43B 106.8M 2024-09
Sino Biopharmaceutical CNY 1.16B 90.25M 2024-06
Tilray USD 316.63M 15.02M 2024-11
Ultragenyx Pharmaceutical USD 0 0 2024-12
United Therapeutics USD 0 0 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12
Zz Pientze Pharmaceu 162.42M 4.3M 2024-09



Moderna العاصمة قرض - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Mar 2025.